Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers
Clinical trial NCT03031535 · COMPLETED
Trial details
- NCT number
- NCT03031535
- Sponsor
- Dauntless Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2017-03-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.